Get the Stockscreener App
87.49
0.36%
0.31
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Merck Co Inc stock is traded at $87.49, with a volume of 7.89M.
It is up +0.36% in the last 24 hours and up +9.82% over the past month.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
See More
Previous Close:
$87.18
Open:
$87.33
24h Volume:
7.89M
Relative Volume:
0.66
Market Cap:
$218.53B
Revenue:
$63.43B
Net Income/Loss:
$16.42B
P/E Ratio:
13.49
EPS:
6.4861
Net Cash Flow:
$14.72B
1W Performance:
+3.18%
1M Performance:
+9.82%
6M Performance:
+9.58%
1Y Performance:
-17.37%
1-Day Range:
$87.11
$88.06
1-Week Range:
$85.03
$88.79
52-Week Range:
$73.31
$106.49
Merck Co Inc Stock (MRK) Company Profile
Name
Merck Co Inc
Sector
Industry
Phone
908-740-4000
Address
126 EAST LINCOLN AVENUE, RAHWAY, NJ
Compare MRK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MRK
Merck Co Inc
|
87.49 | 217.76B | 63.43B | 16.42B | 14.72B | 6.4861 |
|
LLY
Lilly Eli Co
|
825.45 | 736.03B | 53.26B | 13.80B | -50.20M | 15.08 |
|
JNJ
Johnson Johnson
|
190.40 | 463.72B | 92.15B | 25.12B | 18.18B | 10.36 |
|
ABBV
Abbvie Inc
|
227.99 | 403.22B | 58.33B | 3.73B | 18.24B | 2.1013 |
|
NVS
Novartis Ag Adr
|
130.36 | 254.84B | 53.40B | 13.68B | 16.89B | 6.8864 |
Merck Co Inc Stock (MRK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-13-25 | Resumed | Citigroup | Neutral |
| Sep-17-25 | Downgrade | Berenberg | Buy → Hold |
| May-14-25 | Downgrade | Citigroup | Buy → Neutral |
| Apr-22-25 | Initiated | Cantor Fitzgerald | Neutral |
| Feb-18-25 | Downgrade | Deutsche Bank | Buy → Hold |
| Feb-10-25 | Downgrade | TD Cowen | Buy → Hold |
| Jan-08-25 | Downgrade | Truist | Buy → Hold |
| Dec-20-24 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Dec-10-24 | Resumed | BofA Securities | Buy |
| Dec-04-24 | Upgrade | HSBC Securities | Hold → Buy |
| Nov-15-24 | Initiated | Wolfe Research | Peer Perform |
| Nov-11-24 | Downgrade | Daiwa Securities | Buy → Neutral |
| Oct-17-24 | Initiated | Bernstein | Mkt Perform |
| Mar-11-24 | Downgrade | Societe Generale | Hold → Sell |
| Jan-04-24 | Upgrade | TD Cowen | Market Perform → Outperform |
| Nov-09-23 | Initiated | Deutsche Bank | Buy |
| Oct-27-23 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Oct-20-23 | Upgrade | UBS | Neutral → Buy |
| Jul-14-23 | Initiated | HSBC Securities | Hold |
| Apr-13-23 | Upgrade | Citigroup | Neutral → Buy |
| Mar-28-23 | Downgrade | Societe Generale | Buy → Hold |
| Mar-13-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Mar-06-23 | Initiated | Jefferies | Buy |
| Feb-22-23 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jan-04-23 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-18-22 | Initiated | Credit Suisse | Outperform |
| Oct-10-22 | Upgrade | Guggenheim | Neutral → Buy |
| Sep-14-22 | Upgrade | Berenberg | Hold → Buy |
| Jul-06-22 | Upgrade | Daiwa Securities | Neutral → Buy |
| Jun-06-22 | Resumed | SVB Leerink | Outperform |
| Apr-06-22 | Resumed | Morgan Stanley | Equal-Weight |
| Dec-17-21 | Initiated | Goldman | Buy |
| Dec-16-21 | Initiated | Daiwa Securities | Neutral |
| Dec-13-21 | Downgrade | UBS | Buy → Neutral |
| Dec-09-21 | Initiated | Wells Fargo | Overweight |
| Dec-07-21 | Downgrade | Guggenheim | Buy → Neutral |
| Nov-29-21 | Downgrade | Citigroup | Buy → Neutral |
| Nov-19-21 | Initiated | BMO Capital Markets | Market Perform |
| Nov-01-21 | Upgrade | Argus | Hold → Buy |
| Sep-07-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-27-21 | Resumed | Truist | Buy |
| May-20-21 | Downgrade | Argus | Buy → Hold |
| Apr-07-21 | Resumed | RBC Capital Mkts | Sector Perform |
| Nov-10-20 | Resumed | Bernstein | Outperform |
| Sep-29-20 | Initiated | Berenberg | Hold |
| Aug-03-20 | Upgrade | Goldman | Neutral → Buy |
| Jun-12-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Feb-27-20 | Initiated | Barclays | Overweight |
| Jan-07-20 | Initiated | RBC Capital Mkts | Sector Perform |
| Oct-17-19 | Resumed | BofA/Merrill | Neutral |
| Aug-16-19 | Initiated | SVB Leerink | Outperform |
| Jul-03-19 | Initiated | Mizuho | Buy |
| May-28-19 | Initiated | Goldman | Neutral |
| May-13-19 | Upgrade | Atlantic Equities | Neutral → Overweight |
| Oct-16-18 | Reiterated | Citigroup | Buy |
| Oct-09-18 | Resumed | Guggenheim | Buy |
| Apr-23-18 | Upgrade | Goldman | Neutral → Buy |
| Apr-17-18 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-05-18 | Upgrade | Barclays | Equal Weight → Overweight |
| Mar-12-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
| Feb-14-18 | Reiterated | Leerink Partners | Mkt Perform |
| Feb-07-18 | Reiterated | Morgan Stanley | Equal-Weight |
| Jan-16-18 | Upgrade | SunTrust | Hold → Buy |
View All
Merck Co Inc Stock (MRK) Latest News
Kornitzer Capital Management Inc. KS Grows Stock Position in Merck & Co., Inc. $MRK - MarketBeat
B & T Capital Management DBA Alpha Capital Management Acquires 4,072 Shares of Merck & Co., Inc. $MRK - MarketBeat
SSA Swiss Advisors AG Purchases 7,180 Shares of Merck & Co., Inc. $MRK - MarketBeat
Focus Partners Advisor Solutions LLC Has $6 Million Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Stake Boosted by Keeler Thomas Management LLC - MarketBeat
State of New Jersey Common Pension Fund D Sells 4,014 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Bought by Leelyn Smith LLC - MarketBeat
Merck & Co., Inc. $MRK Shares Bought by PKO Investment Management Joint Stock Co - MarketBeat
Cardinal Point Capital Management ULC Makes New Investment in Merck & Co., Inc. $MRK - MarketBeat
Merck Q3 Earnings Preview: Issues That Will Dominate The Agenda (NYSE:MRK) - Seeking Alpha
Lee Danner & Bass Inc. Trims Stock Position in Merck & Co., Inc. $MRK - MarketBeat
West Michigan Advisors LLC Sells 35,956 Shares of Merck & Co., Inc. $MRK - MarketBeat
Sumitomo Mitsui Trust Group Inc. Has $588.68 Million Stake in Merck & Co., Inc. $MRK - MarketBeat
Sector Gamma AS Takes Position in Merck & Co., Inc. $MRK - MarketBeat
Moloney Securities Asset Management LLC Has $2.59 Million Position in Merck & Co., Inc. $MRK - MarketBeat
Jackson Hole Capital Partners LLC Increases Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Bought by Generali Investments Towarzystwo Funduszy Inwestycyjnych - MarketBeat
ARGA Investment Management LP Raises Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
GLOBALT Investments LLC GA Trims Stake in Merck & Co., Inc. $MRK - MarketBeat
Caitong International Asset Management Co. Ltd Invests $490,000 in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Bought by 180 Wealth Advisors LLC - MarketBeat
Bleakley Financial Group LLC Has $5.52 Million Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Brookstone Capital Management - MarketBeat
Betamethasone Acetate Market Is Booming So Rapidly |Merck & Co., Inc., American Regent, Inc. - openPR.com
Why Some Investors Are Taking Profits on JPMorgan After Its Big Rally - The Motley Fool
Stock of the WeekMerck & Co Inc (23.10.2025) - XTB.com
FSM Wealth Advisors LLC Acquires 4,003 Shares of Merck & Co., Inc. $MRK - MarketBeat
Strata Wealth Advisors LLC Takes Position in Merck & Co., Inc. $MRK - MarketBeat
First Citizens Bank & Trust Co. Sells 17,254 Shares of Merck & Co., Inc. $MRK - MarketBeat
Loring Wolcott & Coolidge Fiduciary Advisors LLP MA Sells 14,614 Shares of Merck & Co., Inc. $MRK - MarketBeat
Clifford Swan Investment Counsel LLC Sells 2,872 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck Keytruda formulations undergo FDA priority review for bladder cancer - Seeking Alpha
RNC Capital Management LLC Reduces Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Freedom Investment Management Inc. Grows Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Forum Financial Management LP Sells 4,413 Shares of Merck & Co., Inc. $MRK - MarketBeat
Caliber Wealth Management LLC KS Decreases Stake in Merck & Co., Inc. $MRK - MarketBeat
Merck to Present New Data from Its Innovative Cardio-Pulmonary Pipeline and Portfolio at AHA Scientific Sessions 2025 - FinancialContent
Merck & Co., Inc. (MRK) Projected to Post Quarterly Earnings on Thursday - MarketBeat
Cancer Drugs Market Is Booming So Rapidly | Pfizer Inc., Novartis AG, Merck & Co., Inc. - openPR.com
Ethic Inc. Buys 8,003 Shares of Merck & Co., Inc. $MRK - MarketBeat
Birch Hill Investment Advisors LLC Reduces Holdings in Merck & Co., Inc. $MRK - MarketBeat
Steel Grove Capital Advisors LLC Raises Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Family Capital Management Inc. Buys 5,122 Shares of Merck & Co., Inc. $MRK - MarketBeat
D.A. Davidson & CO. Has $43.22 Million Position in Merck & Co., Inc. $MRK - MarketBeat
Cullen Frost Bankers Inc. Sells 8,890 Shares of Merck & Co., Inc. $MRK - MarketBeat
Avidian Wealth Enterprises LLC Decreases Holdings in Merck & Co., Inc. $MRK - MarketBeat
MRK Stock Quote Price and Forecast - CNN
Analyst Says He’s Buying Merck (MRK) as ‘Market Turns Towards Quality’ - Insider Monkey
Beech Hill Advisors Inc. Trims Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Fiduciary Family Office LLC Has $1.03 Million Position in Merck & Co., Inc. $MRK - MarketBeat
Whittier Trust Co. of Nevada Inc. Has $21.38 Million Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck Co Inc Stock (MRK) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.51%
0.17%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):